Ireland’s Health Research Board awards €1.2M to UL researchers

NewsGuard 100/100 Score

University of Limerick (UL) researchers have been awarded over €1.2 million funding by Ireland’s Health Research Board. The funding will support health research focused on; primary care reform in Ireland; avoidance of adverse outcomes in vascular surgery; dealing with the progression of chronic kidney disease and enhancing physical activity for multiple sclerosis patients. The overarching aim of the research is to improve patient care and health outcomes.

Dr Mary Shire, Vice President Research, UL said; “Health research at the University of Limerick has the patient at its center. We are working in partnership with health service providers, community organisations and industry to enhance the health of Irish people and support the adoption of innovative approaches to health services delivery. This HRB funding is an important validation of the significance this research has for patient care and healthcare reform in Ireland.”

The funding has been allocated to four Principal Investigators at UL:

Professor Austin Stack, Chair of Medicine UL and Consultant Nephrologist at Limerick University Hospital: ‘Assessing the burden and progression of chronic kidney disease in the Irish Health System’

Dr Susan Coote, University of Limerick, ‘Enhancing Physical Activity Behaviour in People with Multiple Sclerosis.

Professor Anne MacFarlane, Chair of Primary Health Care Research, Graduate Entry Medical School: ‘Primary Care reform in Ireland – an analysis of ‘top down’ and ‘bottom up’ innovation’

Professor Stewart Walsh, Professor of Vascular Surgery, UL and Consultant Vascular Surgeon, University Hospital Limerick: ‘Preconditioning shields against vascular events in surgery (Preconditioning-SAVES): A multi-centre feasibility trial of preconditioning against adverse events in major vascular surgery’

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Microfluidic chips advance neurodegenerative disease research